SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-079685
Filing Date
2009-04-15
Accepted
2009-04-15 16:30:45
Documents
4
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008 d10k.htm 10-K 789731
2 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 302 dex311.htm EX-31.1 10130
3 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4545
4 GRAPHIC g92500g70l52.jpg GRAPHIC 6593
  Complete submission text file 0001193125-09-079685.txt   815353
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33004 | Film No.: 09751407
SIC: 2834 Pharmaceutical Preparations